Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Classification of Triple-Negative Breast Cancer
Sung Gwe Ahn, Seung Jun Kim, Cheungyeul Kim, et al.
Journal of Breast Cancer (2016) Vol. 19, Iss. 3, pp. 223-223
Open Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
Javier Cortés, Hope S. Rugo, David W. Cescon, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 3, pp. 217-226
Open Access | Times Cited: 640
Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
Javier Mauricio Medina Salcedo, Goldie Oza, Ashutosh Sharma, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 6, pp. 2078-2078
Open Access | Times Cited: 253
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
Lorenzo Gerratana, Debora Basile, Giuseppe Buono, et al.
Cancer Treatment Reviews (2018) Vol. 68, pp. 102-110
Open Access | Times Cited: 225
Heterogeneity of breast cancer: The importance of interaction between different tumor cell populations
Indrė Januškevičienė, Vilma Petrikaitė
Life Sciences (2019) Vol. 239, pp. 117009-117009
Closed Access | Times Cited: 164
Integrating multiple machine learning methods to construct glutamine metabolism-related signatures in lung adenocarcinoma
Pengpeng Zhang, Shengbin Pei, Leilei Wu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 45
Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies
Nating Xiong, Heming Wu, Zhikang Yu
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 21
Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p
Shuqin Li, Jun Zhou, Zhaoxin Wang, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 104, pp. 451-457
Closed Access | Times Cited: 151
CLCA2 expression is associated with survival among African American women with triple negative breast cancer
Kristen S. Purrington, Jimmie Knight, Gregory Dyson, et al.
PLoS ONE (2020) Vol. 15, Iss. 4, pp. e0231712-e0231712
Open Access | Times Cited: 128
Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogen and Its Receptors in Cancer Physiopathology
Mariana Segovia‐Mendoza, Jorge Morales‐Montor
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 115
Epithelial–Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance
Alex J. Gooding, William P. Schiemann
Molecular Cancer Research (2020) Vol. 18, Iss. 9, pp. 1257-1270
Open Access | Times Cited: 115
Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms
Zeinab Safarpour Lima, Mostafa Ghadamzadeh, Farzad Tahmasebi Arashloo, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 104
Neoadjuvant Chemotherapy for Breast Cancer: Past, Present, and Future
Mariko Asaoka, Shipra Gandhi, Takashi Ishikawa, et al.
Breast Cancer Basic and Clinical Research (2020) Vol. 14
Open Access | Times Cited: 101
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
Pascal Jézéquel, Olivier Kerdraon, Hubert Hondermarck, et al.
Breast Cancer Research (2019) Vol. 21, Iss. 1
Open Access | Times Cited: 97
Novel mechanism of cannabidiol-induced apoptosis in breast cancer cell lines
Ahmed Sultan, Mona A. Marie, Salah A. Sheweita
The Breast (2018) Vol. 41, pp. 34-41
Closed Access | Times Cited: 96
A Light-Triggered Mesenchymal Stem Cell Delivery System for Photoacoustic Imaging and Chemo-Photothermal Therapy of Triple Negative Breast Cancer
Chang Xu, Qishuai Feng, Hao‐Cheng Yang, et al.
Advanced Science (2018) Vol. 5, Iss. 10
Open Access | Times Cited: 94
The role of PARP inhibition in triple-negative breast cancer: Unraveling the wide spectrum of synthetic lethality
Marios Papadimitriou, Giannis Mountzios, Christos Papadimitriou
Cancer Treatment Reviews (2018) Vol. 67, pp. 34-44
Closed Access | Times Cited: 91
Triple‑negative breast cancer: A run‑through of features, classification and current therapies (Review)
Meghana Manjunath, Bibha Choudhary
Oncology Letters (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 74
Emerging Role of PARP Inhibitors in Metastatic Triple Negative Breast Cancer. Current Scenario and Future Perspectives
Giacomo Barchiesi, Michela Roberto, Monica Verrico, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 66
Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
Edris Choupani, Mohammad Mahmoudi Gomari, Saeed Zanganeh, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 2, pp. 309-327
Open Access | Times Cited: 39
Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells
Snahlata Singh, Rumela Chakrabarti
Journal of Clinical Medicine (2019) Vol. 8, Iss. 5, pp. 642-642
Open Access | Times Cited: 67
The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge
Daiana Cosmina Temian, Laura Pop, Alexandra Iulia Irimie, et al.
Journal of Breast Cancer (2018) Vol. 21, Iss. 3, pp. 233-233
Open Access | Times Cited: 66
Asymmetric Heterodimer-Regulated Surface Plasmon Coupling ECL Polarization Strategy for MiRNA-182 Detection
Zihui Liang, Xiaoyi Yan, Junyi Zhao, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 26, pp. 9990-9998
Closed Access | Times Cited: 17
Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants
Kiven Erique Lukong, Yetunde Ogunbolude, Jean Paul Kamdem
Breast Cancer Research and Treatment (2017) Vol. 166, Iss. 2, pp. 351-365
Closed Access | Times Cited: 61
Subchronic toxicity, immunoregulation and anti-breast tumor effect of Nordamnacantal, an anthraquinone extracted from the stems of Morinda citrifolia L
Nadiah Abu, Nur Rizi Zamberi, Swee Keong Yeap, et al.
BMC Complementary and Alternative Medicine (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 53
Estrogen receptor-beta is a potential target for triple negative breast cancer treatment
David Austin, Nalo Hamilton, Yahya Elshimali, et al.
Oncotarget (2018) Vol. 9, Iss. 74, pp. 33912-33930
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top